Piramal Pharma Solutions announce $80 M investment plan to expand its Lexington, Kentucky facility

The expansion will add 24,000 square feet of manufacturing space

Piramal Pharma Solutions, a part of Piramal Pharma, has announced an $80M investment plan to expand its Lexington, Kentucky facility. This expansion will add 24,000 square feet of manufacturing space, a new laboratory, and state-of-the-art machinery, enabling the site to scale clients’ products more effectively. With this investment, Piramal Pharma strengthens its position as a trusted global partner for biologics manufacturing, leveraging deep scientific expertise and extensive experience in managing complex technical projects.

Nandini Piramal, Chairperson, Piramal Pharma, stated, "This expansion represents a strategic investment in the future of Piramal Pharma. Filling the commercial manufacturing gap enables the Lexington site to access the rapidly expanding injectables market and establish itself as a key player in this segment."